SCHEMBL14070272

SCHEMBL14070272

Cc1cccc(C(=O)Nc2ccc(C)c(Nc3nn(C)c4nc(N)ncc34)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 4/20 0.54
▸ KDR P35968 3/20 0.50
▸ INSR P06213 2/20 0.50
▸ LCK P06239 2/20 0.50
▸ LYN P07948 2/20 0.50
▸ HCK P08631 2/20 0.50
▸ SRC P12931 2/20 0.50
▸ CSF1R P07333 1/20 0.49
▸ KIT P10721 1/20 0.49
▸ MAPK14 Q16539 3/20 0.47
▸ NPC1 O15118 4/20 0.45
▸ RAB9A P51151 4/20 0.45
▸ BRAF P15056 4/20 0.45
▸ PDGFRB P09619 2/20 0.45
▸ MAPK10 P53779 2/20 0.45
▸ ESYT2 A0FGR8 1/20 0.45
▸ PLEKHG3 A1L390 1/20 0.45
▸ NBAS A2RRP1 1/20 0.45
▸ CNOT1 A5YKK6 1/20 0.45
▸ TBKBP1 A7MCY6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14070273 0.91 BTK (0.52) BTKKDRINSRLCKLYN
SCHEMBL14070268 0.90 BTK (0.51) BTKKDRINSRLCKLYN
SCHEMBL14069588 0.89 BTK (0.67) BTKKDRINSRLCKLYN
SCHEMBL14070059 0.84 BTK (0.49) BTKKDRINSRLCKLYN
SCHEMBL14070274 0.82 BRAF (0.57) BTKCSF1RBRAFRAF1
SCHEMBL14070288 0.81 BTK (0.55) BTKKDRINSRLCKLYN
SCHEMBL14069739 0.80 BTK (0.44) BTKMAPK14SYKMAPKAPK2
SCHEMBL14070061 0.79 KDR (0.52) BTKKDRINSRLCKLYN
SCHEMBL20558521 0.79 BTK (0.67) BTKKDRINSRLCKLYN
SCHEMBL14069733 0.78 BTK (0.74) BTKKDRINSRLCKLYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008112695-A2 PYRAZOLO [3,4-D] PYRIMIDINES AND 1, 2, 5, 6-TETRAAZA- AS- INDACENES AS PROTEIN KINASE INHIBITORS FOR CANCER TREATMENT IRM LLC (BM) 2008-09-18 — — WO disclosed
Send feedback